These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30449258)

  • 1. Pharmacoinformatics-based identification of chemically active molecules against Ebola virus.
    Islam MA; Pillay TS
    J Biomol Struct Dyn; 2019 Sep; 37(15):4104-4119. PubMed ID: 30449258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
    Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
    Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of inhibitors as potential remedial against Ebolavirus infection: pharmacophore-based approach.
    Sankar M; K L; Jeyachandran S; Pandi B
    J Biomol Struct Dyn; 2021 Feb; 39(2):395-408. PubMed ID: 31928158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics and combined docking studies for the identification of Zaire ebola virus inhibitors.
    Sulaiman KO; Kolapo TU; Onawole AT; Islam MA; Adegoke RO; Badmus SO
    J Biomol Struct Dyn; 2019 Aug; 37(12):3029-3040. PubMed ID: 30058446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel VP35 inhibitors: Virtual screening driven new scaffolds.
    Ren JX; Zhang RT; Zhang H; Cao XS; Liu LK; Xie Y
    Biomed Pharmacother; 2016 Dec; 84():199-207. PubMed ID: 27657828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-secretase inhibitors for Alzheimer's disease: identification using pharmacoinformatics.
    Islam MA; Pillay TS
    J Biomol Struct Dyn; 2019 Feb; 37(2):503-522. PubMed ID: 29388503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modelling studies on adamantane-based Ebola virus GP-1 inhibitors using docking, pharmacophore and 3D-QSAR.
    Mali SN; Chaudhari HK
    SAR QSAR Environ Res; 2019 Mar; 30(3):161-180. PubMed ID: 30786763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
    Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
    J Mol Graph Model; 2018 Jan; 79():88-102. PubMed ID: 29156382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation.
    Hou J; Zou Q; Wang Y; Gao Q; Yao W; Yao Q; Zhang J
    J Biomol Struct Dyn; 2019 Aug; 37(12):3135-3149. PubMed ID: 30079817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand and structure-based computational designing of multi-target molecules directing FFAR-1, FFAR-4 and PPAR-G as modulators of insulin receptor activity.
    Mishra S; Rajput MS; Rathore D; Dahima R
    J Biomol Struct Dyn; 2022 Sep; 40(15):6974-6988. PubMed ID: 33648410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40.
    Mirza MU; Ikram N
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herbal Lead as Ideal Bioactive Compounds Against Probable Drug Targets of Ebola Virus in Comparison with Known Chemical Analogue: A Computational Drug Discovery Perspective.
    Setlur AS; Naik SY; Skariyachan S
    Interdiscip Sci; 2017 Jun; 9(2):254-277. PubMed ID: 26857866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the therapeutic potential of galidesivir analogs against Zaire ebolavirus protein 24 (V24): database screening, molecular docking, drug-relevant property evaluation and molecular dynamics simulations.
    Hassan HA; Abdelwahab SF; Al-Khdhairawi A; Al Zrkani MK; Rehman HM; Abdel-Rahman IM; El-Sheikh AAK; Abdelhamid MM
    J Biomol Struct Dyn; 2024 Aug; 42(13):6761-6771. PubMed ID: 37477257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
    Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
    Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
    Qiu Y; Zhou L; Hu Y; Bao Y
    J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.